Immupharma took the stairs #bearishIMM matches the adage, "Markets take the stairs up and the elevator down".
Short
ImmuPharma plc
No trades
No trades
Compare with ImmuPharma plc
−0.005 GBP
−1.81 M GBP
0.00 GBP
491.70 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Details
Sector
Industry
CEO
Timothy Paul McCarthy
Website
Headquarters
London
Founded
2000
IPO date
Oct 28, 2003
ISIN
GB0033711010
FIGI
BBG000C01SG5
Identifiers
ISIN GB0033711010
ImmuPharma PLC engages in the research, development, and commercialization of pharmaceutical products. It is focused on the development of drugs, primarily based on peptide therapeutics, to treat serious medical conditions such as autoimmune diseases. The firm's portfolio consists of four novel peptide therapy areas: autoimmunity, metabolism, cancer and anti-infectives. Its drug Lupuzor, is a potential treatment for the autoimmune chronic inflammatory disease lupus. The company was founded by Richard Warr and Dimitri F. Dimitriou in 1999 and is headquartered in London, the United Kingdom.
Short
Immupharma - Risen from the dead or dad cat bounce?All signs look to a dead cat bounce. Obviosuly everyone knows this has been trending down for almost 2 years.
This has no consolidation under the 32p resistance, a weekly close under the previous 19p support is not a good look.
Very good news was fomo'd into. Next news should be a while, thi
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of IMM is 3.600 GBX — it has decreased by −0.67% in the past 24 hours. Watch ImmuPharma plc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange ImmuPharma plc stocks are traded under the ticker IMM.
IMM stock has risen by 0.68% compared to the previous week, the month change is a −6.09% fall, over the last year ImmuPharma plc has showed a 100.56% increase.
IMM stock is 25.00% volatile and has beta coefficient of 1.07. Track ImmuPharma plc stock price on the chart and check out the list of the most volatile stocks — is ImmuPharma plc there?
Today ImmuPharma plc has the market capitalization of 23.08 M, it has increased by 7.14% over the last week.
Yes, you can track ImmuPharma plc financials in yearly and quarterly reports right on TradingView.
ImmuPharma plc is going to release the next earnings report on Sep 24, 2026. Keep track of upcoming events with our Earnings Calendar.
IMM net income for the last half-year is 31.21 K GBP, while the previous report showed −1.84 M GBP of net income which accounts for 0.00% change. Track more ImmuPharma plc financial stats to get the full picture.
No, IMM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IMM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ImmuPharma plc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ImmuPharma plc technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ImmuPharma plc stock shows the sell signal. See more of ImmuPharma plc technicals for a more comprehensive analysis.